2015
DOI: 10.1016/s1474-4422(15)00012-5
|View full text |Cite
|
Sign up to set email alerts
|

Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial

Abstract: SummaryBackgroundBrain scans are essential to exclude haemorrhage in patients with suspected acute ischaemic stroke before treatment with alteplase. However, patients with early ischaemic signs could be at increased risk of haemorrhage after alteplase treatment, and little information is available about whether pre-existing structural signs, which are common in older patients, affect response to alteplase. We aimed to investigate the association between imaging signs on brain CT and outcomes after alteplase.Me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
101
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 166 publications
(106 citation statements)
references
References 41 publications
3
101
0
1
Order By: Relevance
“…4, 6, 14, 15, 18, 19 The pooled incidence of poor outcome (defined as mRS>2 in three studies, 6, 14, 18 mRS≥2 in two studies 15, 19 ) was 47% (95%CI: 34%–60%) in the leukoaraiosis negative group compared to 64% (95%CI: 55%–74%) in the leukoaraiosis positive group. Pooled analysis of these studies demonstrated the odds of poor outcome at 3–6 month post-stroke to be significantly elevated in those with evidence of leukoaraiosis (OR: 2.02; 95%CI: 1.54–2.65, p<0.0001, Figure 3A), with significant statistical heterogeneity between studies (I 2 :73.5%, p=0.002).…”
Section: Resultsmentioning
confidence: 98%
See 1 more Smart Citation
“…4, 6, 14, 15, 18, 19 The pooled incidence of poor outcome (defined as mRS>2 in three studies, 6, 14, 18 mRS≥2 in two studies 15, 19 ) was 47% (95%CI: 34%–60%) in the leukoaraiosis negative group compared to 64% (95%CI: 55%–74%) in the leukoaraiosis positive group. Pooled analysis of these studies demonstrated the odds of poor outcome at 3–6 month post-stroke to be significantly elevated in those with evidence of leukoaraiosis (OR: 2.02; 95%CI: 1.54–2.65, p<0.0001, Figure 3A), with significant statistical heterogeneity between studies (I 2 :73.5%, p=0.002).…”
Section: Resultsmentioning
confidence: 98%
“…46, 12–19 For the ECASS-1/−2 report (published only as an abstract), we contacted the lead authors to provide relevant data for the meta-analysis. 18 A summary of the characteristics of included studies, methodological key issues and quality indicators are noted in Table 1.…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, WMH increase risk of brain damage in the presence of other pathologies, for example, they associate with infarct growth and worse outcome after large artery stroke,60,61 and they predict poor functional stroke outcome 6264…”
Section: Clinical Importancementioning
confidence: 99%
“…This study cohort included 2099 ischemic stroke patients showing unilateral acute ischemic changes in follow-up neuroimaging studies according to the expert central review ( Figure I in the online-only Data Supplement). 18 All scans were systematically assessed by neuroradiologists or stroke neurologists expert in stroke imaging, masked to all clinical data. 19 The definitions for cerebral infarcts involving the insular cortex, stroke severity, and lesion size are provided in the online-only Data Supplement.…”
Section: Strokementioning
confidence: 99%